Until now, it has been hypothesized that CD26/DPP4 plays a crucial role in the onset and course of allergic inflammations (Ohnuma et al. 2005), but to our knowledge no experimental studies trying to modulate asthma have been published. Here, DPP4 is linked to asthma.